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Abstract 
 
Qualitative somatosensory testing (QualST) is a simple chairside test. It can be used to roughly assess 
the presence or absence of altered somatosensory function. To use QualST clinically, it is important to 
assess its agreement with quantitative sensory testing (QST). The aims of this study were to assess the 
agreement between QST and QualST when testing the modulation of facial sensitivity by capsaicin in 
healthy participants and to explore the agreement between QST and QualST in assessing the intraoral 
sensory function in clinical atypical odontalgia (AO) patients. Eighteen healthy pain-free adults and 
data from 27 AO patients were included in the study. 
Thirteen QST and three QualST parameters were evaluated at each site. Z-scores were computed for 
healthy participants and LossGain scores were created. The agreement observed between QST and 
QualST in participants with no alterations in facial sensation (placebo) was good, i.e. ranging from 
89% to 94%. A poorer agreement was seen after capsaicin application in all test modalities with 
agreement ranging from 50% to 72%. The commonest misclassification observed was participants 
classified as normal according to QST, but hyper- or hyposensitive according to QualST after 
capsaicin application, especially for cold and pinprick. A similar trend was observed in AO patients 
where patients classified as normal using QST were misclassified as hypersensitive and in few 
patients as hyposensitive by QualST.  In conclusion, the study showed that QualST may be used as a 
screening tool in the clinical setting, especially to show that subjects have normal sensory function. 
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capsaicin; placebo; somatosensory profiling; quantitative sensory testing, qualitative sensory testing; 
atypical odontalgia 
 
 
 
Page 2 of 30
N/A
Journal of Oral Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 3 
Background 
Nerve damage and altered sensation are common complications of orofacial trauma and some oral and 
maxillofacial treatments 
1-3
. The resulting effect can range from mild complications such as transient 
hypoesthesia to life changing effects such as neuropathic pain 4-7. Clinical symptoms of nerve damage 
such as altered sensations, e.g. somatosensory impairment, allodynia, persistent pain, pain and 
discomfort in the orofacial region, usually interfere negatively with daily activities 
8
. Persistent 
uncontrollable postoperative pain and neuropathic pain are disabling iatrogenic conditions with severe 
medical, economic and psychological implications 9-11. Early detection of nerve damage may aid 
treatment planning of nerve repair and lead to a reduction of the sensory impairment 
6,12-16
.  
A standardized battery of quantitative sensory testing (QST) was developed in 2006 by the 
German Research Network on Neuropathic Pain (Deutscher Forschungsverbund Neuropathischer 
Schmerz (DFNS)) to study somatosensory function 
17
. This protocol has been proven to be 
sufficiently reliable for evaluation of gain or loss of somatosensory function at several body sites 
including the orofacial region 
18-21
. The somatosensory profiles obtained from QST may be used to 
explore mechanisms behind different pain conditions but with regards to neuropathic pain, 
somatosensory profiles may vary quite a lot even within the same condition 20,22.  
Though QST is sufficiently reliable, its application in the clinical setting is limited as a result 
of a need for highly trained personnel required to operate the required equipment as well as the 
amount of time needed  to complete the full battery of tests 23. Therefore, a simpler and more 
qualitative clinical method to assess somatosensory testing has been advocated by some authors 
23-26
.  
Qualitative somatosensory testing (QualST) is an example of such a simple chairside test 23,26. It can 
be used to roughly assess the presence or not of altered somatosensory function. It is simple to apply 
and no extensive training and expensive equipment are needed. The test takes less than 5 min to 
perform but it provides information about crude hyposensitivity or hypersensitivity to touch, cold and 
pinprick stimuli. Though other stimulus modalities exist 27 these modalities cover the function of both 
Aβ-, Aδ and C-fibers 
23
. QualST has been tested intraorally with promising results 
23
. As a screening 
tool, it can be used as the first diagnostic method and patients that show altered sensation can then be 
referred to undertake a full battery of QST to better document their condition. This may possibly save 
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time and costs and allow screening before and after surgery, especially in procedures with possible 
risk of nerve damage. However, in order to be able to recommend this test in the future, it is important 
to assess its agreement with QST.  
The aim of this study was therefore to assess the level of agreement between quantitative and 
qualitative sensory testing of experimental modulation of facial sensitivity with capsaicin in a 
randomized placebo-controlled cross-over manner in healthy individuals. We hypothesized that the 
agreement between QualST and QST was sufficient for QualST to be used as a screening tool in the 
clinical setting. Another aim was to further explore the agreement between QST and QualST in 
assessing the intraoral somatosensory function in clinical atypical odontalgia (AO) patients. 
 
Materials and Methods 
Eighteen healthy pain-free adults (> 18 years) were included in the study (10 women, 8 men, mean 
age (± SD) 30.9 ± 5.8 years). The participants were recruited through advertisements at Aarhus 
University and the local community. The inclusion criteria were: > 18 years old. Exclusion criteria 
were: known systemic problems, current or previous radiotherapy or chemotherapy, intake of any type 
of analgesics in the last 24 hours prior to the study, presence of any orofacial pain conditions, 
presence of self-reported psychiatric or personality disorders. The sample size was based on 
knowledge from earlier studies 17-19,21,22 on the variance of QST measures performed in the orofacial 
region taking into account the paired study design. 
The study was performed in accordance with the Helsinki Declaration II.  The study protocol 
was approved by the ethics committee of Central Denmark Region. Full explanation of all procedures 
was given to all participants, after which they signed a written informed consent.  
Data from an earlier study using QST and QualST in the chronic intraoral pain condition AO 
patients were further explored23. The 27 AO patients consist of 23 women and 4 men with a mean age 
(± SD) of 63 ± 14 years). 
 
Study Design 
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The study was designed as a randomized, placebo-controlled cross-over study. All healthy 
participants were evaluated in two sessions by the same male examiner (one session per tested 
condition).  The tested conditions were: Topical capsaicin and placebo. The tested areas were the right 
or left infraorbital region of the participants. The condition as well as test side were randomly chosen 
for each participant. Participants were blinded to the condition being tested. Each test was separated 
by at least three days. Qualitative sensory testing (QualST) as well as Quantitative sensory testing 
(QST) were performed on the selected side before and after application in each session. 
 
Topical application 
The concentration of capsaicin and the time-period of application were chosen based on the results of 
earlier studies 
25,28
. The topical application of capsaicin was used to provoke mild to moderate pain 
that lasted throughout the test period. In this study, 0.1% capsaicin cream (Capzasin-HP. Chattem, 
Inc, USA) was used to provoke mild to moderate pain and Mepore Pro Plaster (Mölnlycke Healthcare 
AB, Göteborg, Sweden) was used as the placebo. A thin layer of capsaicin applied on a 4x4-cm 
Mepore pro plaster, or a 4x4-cm Mepore pro plaster (placebo), was applied on the infraorbital region 
of participants. Participants were asked to score the perceived pain intensity every minute during the 5 
min of application using a 0-10 Numerical rating scale (NRS) (0 = ‘no pain’, 10 = ‘most pain 
imaginable’).  
 
Measurement process 
Extraoral qualitative sensory testing  The applied QualST technique has been previously described in 
detail 
23
. In short, the sensitivity to touch, cold, and pinprick stimuli were evaluated on the test site 
compared with the contralateral site. The stimuli were applied to the contralateral site first, followed 
by the test site (application side), and always in the same order: (1) touch, (2) cold, and (3) pinprick 23. 
The touch stimulus was applied with a Q-tip in a single stroke over 1 to 2 cm of skin 
23
. The cold 
stimulus was applied with a stainless steel dental spatula (kept cool in ice water, approximately 0°C) 
for 1 to 2 s 23. The pinprick stimulus was applied with a dental examination probe with moderate force 
on the skin for 1 to 2 s 
23 
. Participants were asked to report hypersensitivity, hyposensitivity, or 
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normosensitivity to touch, cold, and painful stimuli on the test site compared with the control 
contralateral site 22,23.  
 
Extraoral quantitative sensory testing A standardized quantitative somatosensory examination, 
according to the protocol of the DFNS for extraoral application, was used 17,29. Briefly, the 
quantitative somatosensory examination was comprised of 13 test parameters and investigated the 
following sensory functions in the following sequence: The tests for thermal sensation were 
performed using a PATHWAY (MEDOC, Ramat Yishai, Israel) thermal sensory testing device. Cold 
detection threshold (CDT) and warmth detection threshold (WDT) were measured first. The number 
of paradoxical heat sensations (PHS) was determined during the thermal sensory limen (TSL) 
procedure, followed by cold pain threshold (CPT) and heat pain threshold (HPT) 
17
. The baseline 
temperature was 32°C, and all thresholds were obtained with ramped stimuli (1°C/ s) that were 
terminated when the participant pressed a button 17. Cut-off temperatures were 0 and 50°C, and the 
contact area of the extra-oral thermode was 9.0 cm
2 17
. During the experiment, the participants were 
discouraged from looking at the computer screen. 
Mechanical detection thresholds (MDTs) were measured using a standardized set of modified 
von Frey filaments (OptiHair; MARSTOCK Nervtest, Marburg, Germany), which exert forces 
between 0.25 and 512 mN 17. The contact area of the von Frey hairs were rounded tips, 0.5 mm in 
diameter, to avoid sharp edges that would facilitate nociceptor activation 17,21. The filament was 
applied perpendicular to the test site, and the pressure was slowly increased until the filament began to 
bend 18. The time needed to bend was standardized to about 1–2 s, and the stimulus was maintained 
for 1–2 s 17,21. The final threshold was the geometric mean of five series of ascending and descending 
stimulus intensities, where the participant was asked to indicate each time a stimulus was perceived 
17,19.  
Mechanical pain thresholds (MPT) were measured using custom-made weighted pinprick 
stimulators (Aarhus University, Aarhus, Denmark) with fixed-stimulus intensities between 8 and 512 
mN 17,22. The final threshold of painful pricking or stinging sensation was the geometric mean of five 
series of ascending and descending stimulus intensities 
17,19
. Mechanical pain sensitivity (MPS) was 
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tested using the same weighted pinprick stimuli as for MPT 17. In addition, dynamic mechanical 
allodynia (ALL) were tested using three light tactile stimulators: a cotton wisp (~3 mN), a cotton- 
wool tip (~100 mN), and a Somedic brush (~200–400 mN) 
17,22
. Each of the seven intensities of 
pinprick and of the three intensities of light stroking was applied five times in a balanced sequence 
and the subjects were asked to give a pain rating for each stimulus on a 0–100 numerical rating scale 
(from 0 = ‘no pain’ to 100 = ‘most pain imaginable’). The MPS was calculated as the geometric mean 
of all pain ratings for pinprick stimuli, and allodynia was calculated as the geometric mean of all pain 
ratings for light touch stimuli 17,21.  
The wind-up ratio (WUR) was evaluated using a single pinprick stimulus and 10 pinprick 
stimuli with the same force, repeated at a rate of 1 Hz and kept constant using a metronome (MA-30; 
Korg, New York, USA) 
17
. Three single pinprick stimuli were alternated with three series of 10 
repeated stimuli. The mean pain rating of the series was then divided by the mean pain rating of single 
stimuli (train/single pinprick) to calculate the WUR 17,21.  
The vibration detection threshold (VDT) test was performed using a Rydel-Seiffer tuning fork 
(64 Hz, 8/8 scale) 17 that was set in motion and placed in contact with the zygomatic arch of maxilla. 
The VDT was determined as a disappearance threshold on the 8/8 scale with three stimulus repetitions 
17,21
.  
The pressure pain threshold (PPT) was measured using a digital pressure algometer 
(SOMEDIC Algometer, SOMEDIC Sales, Hörby, Sweden) with a rubber-coated tip of 1 cm in 
diameter. During the test, pressure was increased at a rate of 50 kPa /s) 
17,21
. At the first painful 
sensation the subjects pressed a button to interrupt stimulation. The PPT was determined as the mean 
of three recordings 17,21. 
 
Statistical analyses 
All absolute QST scores are presented as means ± standard deviation (SD). All QST data, except for 
PHS, CPT, HPT, and VDT, were logarithmically transformed before statistical analysis 
17
. The mean 
and SD of all QST parameters of all healthy subjects at baseline was calculated and served as the 
reference for the Z-transformed QST parameters obtained after application. The QST parameters of 
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each subject were transformed into a Z-score using the following equation: Z-score = (Valuesubject – 
Meanbaseline)/ SDbaseline (negative Z-score: loss of sensory function, positive Z-score: gain in sensory 
function) 
17,22
. Z-scores of >1.96 and <- 1.96 indicate somatosensory sensitivity outside the 95% CI of 
the baseline sensitivity of the healthy subjects 17. P values less than 0.05 were considered statistically 
significant.  
The Loss-Gain score was used to combine a score of somatosensory loss of function (L0, L1, 
L2, or L3) with a score of somatosensory gain of function (G0, G1, G2, or G3) 30,31. The number after 
the ‘L’ or ‘G’ was used to indicate, whether the somatosensory abnormality was related to the thermal 
modalities alone (1), mechanical modalities alone (2) or mixed (3) (thermal and mechanical) 
22
. L0 
and G0 were used to indicate no loss or gain of somatosensory function, respectively. L1 indicated 
isolated loss of small fiber function (if thermal detection thresholds (CDT or WDT) is abnormal); L2 
indicated isolated loss of large fiber function (if mechanical detection thresholds (MDT or VDT) is 
abnormal), and L3 indicated mixed loss of function (if loss of both small and large fiber function) 20,22. 
For somatosensory gain, G1 indicated thermal hyperalgesia, if gain of function in cold or heat pain 
thresholds (CPT or HPT) was found. G2 indicated mechanical hyperalgesia, if gain of function was 
detected for mechanical pain threshold (MPT), mechanical pain sensitivity (MPS), pressure pain 
threshold (PPT) or if the dynamic mechanical allodynia (DMA) score exceeded 0. G3 indicating 
mixed gain of somatosensory function was recorded in individuals with gain of both thermal and 
mechanical somatosensory function 20,22.   
To assess the agreement between QST and QualST, the Z-scores were categorized as normal, 
when Z-scores were between 1.96 and -1.96, hypersensitive, when the Z-scores were >1.96 or 
hyposensitive, when the Z-scores were <-1.96. Using the Loss-Gain coding 30,32, the absolute 
agreement between QualST (3 modalities) and QST (LossGain codes) was calculated as the 
proportion of the group where hyposensitivity to touch in QualST was in agreement with a L2 or L3 
score (both including tactile loss) 22. Similar proportions were computed for the proportions of the 
groups showing agreement between hypersensitivity to touch (QualST) and G2 or G3 score; 
hyposensitivity to cold (QualST) and L1 or L3 score; hypersensitivity to cold (QualST) and G1 or G3 
score; hypersensitivity to pinprick (QualST) and G2 or G3 score 
22
.  
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In addition, the sensitivity and specificity of QualST to detect hyper- and hyposensitivity was 
evaluated using QST as a benchmark. Kappa statistic was not performed in the present study due to its 
shortcomings such as dependence on marginal sum as well as prevalence of examining condition 
33,34
.  
These shortcomings make kappa to have a wide confidence interval that may include anything from 
good to poor agreement 34. Furthermore, a supplementary explorative analysis of data from a previous 
study was done in order to further investigate the agreement between QST and QualST in assessing 
the intraoral sensory function in clinical atypical odontalgia (AO) patients 22. 
NRS pain scores for capsaicin were compared between baseline up till 5 minute post 
application period with a one-way ANOVA test.  
The QST parameters were analyzed with two-way repeated measurements (RM) analyses of 
variance (ANOVAs) with condition (capsaicin and placebo) and time (before and after application) as 
factors. Tukey honestly significant difference (HSD) tests with correction for multiple comparisons 
were used for post hoc analysis when appropriate. All tests were carried out using the STATISTICA, 
v 12 (StatSoft Inc., USA) Statistical Package. 
 
Results  
QST /QualST findings 
The healthy participants’ responses to test conditions as recorded by QST and QualST are presented 
in Table 1. In two-third of healthy participants, QST recorded normal sensation to touch and cold 
after the application of capsaicin, while QualST  recorded only one-third of the participants as having 
normal sensation after capsaicin application. 
 
Agreement between QST and QualST (healthy participants) 
Percentage agreement   
The absolute percentage agreement between corresponding measures from QST and the three 
modalities of QualST is presented in Table 2. The percentage agreement of touch hyposensitivity or 
hypersensitivity for QualST and mechanical loss (L2 or L3) or gain (G2 or G3) from QST was 61% 
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(capsaicin session) and 89% (Placebo), while absolute agreement between cold hyposensitivity or 
hypersensitivity from QualST and QST (L1 or L2) or (G1 or G3) was 50% (Capsaicin) and 89% 
(Placebo). The percentage absolute agreement of hypersensitivity to pinprick for QualST and 
mechanical gain (G2 or G3) from QST was 72% (Capsaicin) and 94% (placebo). Very little absolute 
disagreement between QualST and QST was recorded in the capsaicin session in touch and cold 
modalities (one subject each). In both cases QST indicated hypersensitivity while QualST indicated 
hyposensitivity. 
 
Changes in classification from QST to QualST (healthy participants) 
Using QST as a benchmark, we compared the corresponding score of QualST for the condition and 
test modality used to assess facial sensitivity. Figure 1 shows the classification distribution between 
QST and QualST in healthy participants. There was better agreement after placebo application than 
after capsaicin for all test modalities. 
 
Sensitivity and specificity (healthy participants) 
The sensitivity and specificity of corresponding measures from QST and the three modalities of 
QualST in healthy participants are presented in Table 3. The sensitivity was calculated as the 
probability of a modality being classified as hyper- or hyposensitive with QualST when the subject 
was classified as hyper- or hyposensitive with QST. The sensitivity of QualST modalities to detect 
hyposensitivity ranged from 0.6 to 1.0 with cold modalities presenting the lowest sensitivity after 
application of capsaicin. While the specificity to detect hyposensitivity ranged from 0.5 to 1.0 with 
the lowest specificity value seen in touch modality after application of capsaicin Table 3. 
Since no subject was classified as hyper- or hyposensitive with QST or QualST, no estimate 
(“-“) for the sensitivity was obtained (Table 3). No subjects were classified as hypersensitive in 
conditions such as capsaicin and placebo. All subjects classified as hypersensitive to pinprick by 
QualST was also classified as hypersensitive by QST giving a sensitivity of 1.0. The specificity to 
detect hypersensitivity ranged from 0.7 to 1.0 (Table 3). 
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Agreement between QualST and QST in AO patients 
Changes in classification from QST to QualST (AO patients) The percentage agreement between 
corresponding measures of QST and QualST in AO patients has been published before 
23
. The 
classification distribution between QST and QualST in AO patients when QST is used as the 
benchmark is shown in Fig. 2.  
 
Pain evoked by topical application 
All healthy participants scored application of capsaicin as painful. The mean peak pain induced by 
capsaicin was 8.0 ± 2.0, after 5 min. The mean NRS score after capsaicin application increased with 
time (ANOVA: F = 116.35, p = 0.001) (Fig. 3). No participant scored placebo as painful at any time 
point (Fig. 3). 
 
QST findings (healthy participants) 
There were no significant main effects of session (ANOVA: F = 1.96, p = 0.179) or time (ANOVA: F 
= 7.39, p = 0.014) on CDT scores but there was a statistically significant interaction between session 
and time (ANOVA: F = 13.24, p = 0.002). The post hoc analysis showed that application of capsaicin 
induced a significant decrease in CDT (sensory loss) compared with baseline (Tukey: p = 0.001) and 
placebo (Tukey: p = 0.019) (Fig. 4).  
There were main effects of session (ANOVA: F =11.56, p = 0.003) and time (ANOVA: F = 
11.91, p < 0.001), but without significant interactions, for the WDT. The WDT scores in the capsaicin 
session were significantly lower (sensory gain) compared with the placebo session (Tukey: p < 
0.003). The post hoc analysis of the time effect indicated higher WDTs after applications compared 
with before applications (Tukey: p < 0.001) (Fig. 4).   
There was no significant main effect of session (ANOVA: F = 0.74, p = 0.401) on TSL 
values. However, there was a significant main effect of time (ANOVA: F = 46.09, p < 0.001). The 
post hoc analysis showed significantly higher TSL values (decreased sensitivity) after application 
compared to the pre-application values (P < 0.001) (Fig. 4). 
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There was a main effect of session (ANOVA: F = 7.13, p = 0.016) and time (F = 5.98, p = 
0.026) on CPT. Also, there was a statistically significant interaction between session and time 
(ANOVA: F =1129, p < 0.001). The post hoc analysis of the session effect showed that CPT values 
during the capsaicin session were significantly lower (sensory loss) than in the placebo session 
(Tukey: p < 0.016). The post hoc analysis of the interaction between session and time indicated that 
post application values of CPT during the capsaicin session were lower than at baseline (Tukey: p < 
0.001) and in comparison with post application values in the placebo sessions (Tukey: p < 0.001) 
(Fig. 4). 
There were main effects of session (ANOVA: F = 17.01, p < 0.001) and time (ANOVA: F = 
20.86, p < 0.001) on HPT. Also, there was a statistically significant interaction between session and 
time (ANOVA: F =19.90, p < 0.001). The post hoc analysis of the main session effect indicated that 
the HPT values during the capsaicin session were significantly lower (sensory gain) compared with 
the placebo session (Tukey: p < 0.001). The post hoc analysis of the main effect of time indicated 
slight decreases in HPT values post application compared with baseline (Tukey: p < 0.001). The post 
hoc analysis of the interaction between session and time indicated a significant decrease in HPT after 
capsaicin application compared with baseline (Tukey: p < 0.001) and compared with after application 
of placebo (Tukey: p < 0.0001) (Fig. 4).   
There was a tendency towards a significant main effect of session (ANOVA: F = 4.38, p = 
0.052) on MDT values. However, there was a significant main effect of time (ANOVA: F = 17.64, p 
< 0.001). The post hoc analysis of the time effect indicated higher MDTs after applications compared 
with baseline (Tukey: p < 0.001) (Fig. 5).   
There was no significant main effects of session (ANOVA: F = 0.88, p = 0.362) or time 
(ANOVA: F = 0.77, p < 0.392) on MPT. Also, there was no statistically significant interaction 
between session and time (ANOVA: F =1.00, p = 0.330) (Fig. 5). 
There was a significant main effect of session (ANOVA: F = 4.72, p = 0.044) but no main 
effect of time (ANOVA: F = 1.22, p < 0.284) on MPS values. The post hoc analysis of the session 
effect indicated higher MPS values (sensory gain) in the capsaicin session compared with placebo 
(Tukey: p = 0.044) (Fig. 5). 
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There was no significant main effects of session (ANOVA: F = 0.55, p = 0.468) but a 
tendency towards a significant main effect of time (ANOVA: F = 4.16, p = 0.057) on WUR. Also, 
there was no statistically significant interaction between session and time (ANOVA: F =0.67, p = 
0.423) (Fig. 5). 
There was no significant main effects of session (ANOVA: F = 2.51, p = 0.131) or time 
(ANOVA: F = 1.27, p = 0.275) on VDT scores but there was a statistically significant interaction 
between session and time (ANOVA: F = 9.58, p = 0.006). The post hoc analysis of the interaction 
between session and time indicated significantly lower values of VDT after application of capsaicin 
compared with baseline (Tukey: p < 0.027). 
There was no significant main effect of session (ANOVA: F = 0.30, p = 0.587) or time 
(ANOVA: F = 3.83, p = 0.067) on PPT scores but there was a statistically significant interaction 
between session and time (ANOVA: F = 7.04, p = 0.017). The post hoc analysis of the interaction 
indicated that application of capsaicin induced a significant increase in PPT (sensory loss) compared 
with baseline (Tukey: p = 0.033) (Fig. 5). 
 
Discussion 
This study assessed the level of agreement between quantitative and qualitative sensory testing 
assessing the modulation of facial sensitivity by capsaicin and placebo. The test conditions simulated 
some observed orofacial somatosensory alterations seen after for example after oral surgery. The 
study also reported on the degree of agreement between quantitative and qualitative sensory testing in 
patients with a chronic primary intraoral pain condition, i.e., atypical odontolgia.  
Agreement between QST and QualST 
A good agreement was observed between quantitative and qualitative sensory testing in healthy 
participants with no alterations in facial sensation (placebo) with agreement ranging from 89% to 94% 
of the tested participants. The least agreement was seen after capsaicin application in all test 
modalities with agreement ranging from 50% to 72%. For most conditions the agreement between 
QST and QualST was high for the sensitivity to pinprick (72 - 94%) while the least agreement was 
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observed with sensitivity to cold (Table 2). This finding is in agreement with a previous study where 
good agreement was found between QST and QualST regarding thermal and mechanical modalities in 
healthy subjects 
22
. 
QualST seemed to detect more somatosensory anomaly (hyper/hypo) in all 
sessions/conditions than QST both in healthy participant and AO patients (Tables 1 23). This could 
either mean that QualST tended to induce more false positive responses, or it could mean that the 
sensitivity of QST is low due to the wide range of normal responses. Since no gold standard is 
available, this issue is difficult to settle. However, future studies in clinical patient populations with a 
definite diagnosis of neuropathic pain could be used to observe the degree of agreement between QST 
and QualST in the patients with an electrophysiological or imaging test documenting a nerve lesion.  
Changes in classification between QST and QualST  
Fig. 1 shows the classification distribution between QST and QualST in healthy participants. The best 
agreement was seen in placebo, which indicates that QualST was able to detect normal sensitivity as 
normal in about 90% of cases. The high level of specificity shown by QualST reflects the probability 
that the QualST will be negative among those who, in fact, do not have somatosensory anomaly. The 
commonest misclassification observed was the classification of normal according to QST as 
hyposensitivity by QualST. After capsaicin application, participants classified as normal using QST 
were misclassified as hyper- or hyposensitive using QualST especially for cold and pinprick. A 
similar trend was observed in the further exploration of earlier reported data on AO patients, where 
patients classified as normal using QST were misclassified as hypersensitive and in few patients as 
hyposensitive using QualST (Figure 2). Some patients scored by QST as hypersensitive were scored 
by QualST as hyposensitive especially in touch and pinprick. This misclassification may result from 
differences in the psychophysical method and responses obtained from the patients between the two 
systems (QST and QualST). In QualST, patients were asked to evaluate their sensitivity to the 
different modalities by comparing one side to the other 23,  whereas with QST somatosensory 
sensitivity was evaluated based on the means and SDs of the reference 
17,18
.  
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Although QualST was able to categorize most healthy participants without experimental 
modulation of facial sensitivity as having normal sensory function, its inconsistency in assessing 
facial sensitivity after experimental modulation in healthy participants or in clinical AO patients 
23
 
should be taken into consideration when used for patient screening.  
In all 18 healthy subjects, topical application of capsaicin to the infraorbital region caused a 
severe level of pain. The pain observed in this study was higher than what was reported in a previous 
study, where capsaicin was applied to the gingiva 19. The observed high level of pain in the 
infraorbital region in comparison with gingiva may be due to differences in the C-fiber densities 
between the tissues 
25,35
  
In the present study, the application of capsaicin increased CDT and CPT (decreased 
sensitivity) and reduced HPT (increased sensitivity), which is in accordance with previous studies 
19,36
. These thermal threshold differences were statistically significant in the direct comparison of data 
obtained before and after application. In terms of the mechanical stimuli, topical application of 
capsaicin induced reduced sensitivity to painful mechanical stimuli (the PPT increased), which is in 
accordance with what was obtained with intraoral application, where topical application of capsaicin 
to the attached gingiva induced decreased mechanical sensitivity 19. However, in contrast, other 
studies on the skin have shown increase in mechanical sensitivity after topical application or 
intradermal injection of capsaicin in human subjects 37-39 It could be considered a limitation of the 
present study that capsaicin application may cause the self-unblinding due to its burning sensation. 
However, but we do not believe that this influences the agreement between QST and QualST 
measurements. 
Some of the observed changes in somatosensory sensitivity after topical applications were not 
specific to the application of capsaicin but also occurred after placebo, suggesting that the altered 
sensitivity to some test stimuli (WDT, TSL and MDT) after application could be speculated to be 
sensitizations or adaptations to the stimuli rather than changes induced by application 19,40. This fact 
stresses the need for a control condition in studies such as this.  
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The full QST somatosensory Z-score profile after application of capsaicin and placebo were 
also reported in the present study. The mean and SD of the QST baseline values (before application) 
were used as the reference values to compute the Z-scores as done in previous studies 
19,32,41
. In the 
present study, inspection of the individual Z-scores demonstrated decreased sensitivity towards non-
painful cold, warmth and tactile stimuli and increased sensitivity to pinprick and vibratory stimuli as 
well as increased wind-up after application of capsaicin (Fig. 6). 
However, the other findings observed from the direct comparison of values obtained before 
and after application of the test substances (Fig. 4 & 5) could not be identified in the Z- scores and the 
somatosensory profiles (Fig. 6). This may be due to the natural variation in values that were used to 
create the Z-scores. Thus, the Z-score transformation may only be able to illustrate the most robust 
findings because minor, but still significant, group differences detected in the statistical comparison of 
absolute values were not represented as mean Z-scores outside 95% CI of the baseline values 
36
. 
In summary, we observed and confirmed that a standardized QST battery and Z-score-based 
somatosensory profiling indicated that topical application of capsaicin may be considered as an 
effective surrogate model of extra-oral pain with concomitant somatosensory disturbances. 
 
Conclusion 
In conclusion, the study showed a good level of agreement (89% to 94%) between quantitative and 
qualitative sensory testing in participants with no alterations in facial sensation (placebo). This result 
showed that QualST may be used as a screening tool in the clinical setting, especially to show that 
subjects have normal sensory function. However, in case of experimental modulation of facial 
somatosensory sensitivity as well as in patients with chronic orofacial pain (AO patients) agreement 
was less pronounced between quantitative and qualitative sensory testing.  This has clinical 
implications for the interpretation of QualST as a screening tool in patients with somatosensory 
changes and this should be taken into consideration when it is used in the clinical settings.  
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Figure Legends 
Figure 1: Change in classification from quantitative sensory testing (QST) to qualitative sensory 
testing (QualST) in healthy participants.  0: normal; 1: hypersensitivity; 2: hyposensitivity. 
Figure 2 :  Change in classification from quantitative sensory testing (QST) to qualitative sensory 
testing (QualST) in AO patients. 0: normal; 1: hypersensitivity; 2: hyposensitivity. 
 
Figure 3:  Healthy participants-reported Numerical Rating Scale (NRS) pain scores ± (SEM) after 
the topical application of capsaicin and placebo on the infra-orbital region. The results represent 
mean values (n = 18) obtained during the 5 min recording period. 
 
Figure 4 & 5:  Mean (±SD) of quantitative sensory testing (QST) parameters for tested condition 
before and after application in healthy participants. 
 
Figure 6: Individual Z-score-based quantitative sensory testing (QST) profiles from the infraorbital 
region after the application of capsaicin and placebo in healthy participants and the averaged Z-
scores (C) (n = 18). The grey area (−1.96 < z < 1.96) is the normal range based on the healthy 
reference. CDT: cold detection threshold; WDT: warmth detection; TSL: thermal sensory limen; 
CPT: cold pain threshold; HPT: heat pain threshold; MDT: mechanical detection threshold; MPT: 
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mechanical pain threshold; MPS: mechanical pain sensitivity; WUR: wind-up ratio; VDT: vibration 
detection threshold; PPT: pressure pain threshold. 
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 Table 1: Pooled data for healthy participants’ response to QST and QualST modalities after 
application of Capsaicin and placebo. Each number represents the number of participants scoring 
normal, hyper- or hyposensitivity with QST and QualST 
 
 
 
Table 2: Percentage agreement between QST and QualST (Healthy participants) 
 Capsaicin Placebo 
 Touch (%) Cold (%) Pinprick (%) Touch (%)  Cold (%)  Pinprick (%)  
Absolute Agreement  11(61) 9 (50) 13 (72) 16 (89) 16 (89) 17 (94) 
Disagreement 6 (33) 8 (44) 5 (28) 2 (11) 2 (11) 1 (6) 
Absolute Disagreement 1 (6) 1 (6) 0 (0) 0 (0) 0 (0) 0 (0) 
 
 Capsaicin Placebo 
 TOUCH  COLD PINPRICK  TOUCH  COLD  PINPRICK  
 QST QualST QST QualST QST QualST QST QualST QST QualST QST QualST 
Normal 12 6 12 6 16 5 17 18 18 16 18 17 
Hypersensitivity 0 1 0 4 1 5 0 0 0 0 0 1 
Hyposensitivity 6 11 6 8 1 8 1 0 0 2 0 0 
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Table 3: The Sensitivity, Specificity of QualST given the status of QST (Healthy participants) 
  Hypersensitivity Hyposensitivity 
Parameter Treatment Sensitivity Specificity Sensitivity Specificity 
Touch Capsaicin - 0.94 0.83 0.50 
Placebo - 1.00 - 1.00 
Cold Capsaicin - 0.78 0.67 0.67 
Placebo - 1.00 - 0.89 
Pinprick Capsaicin 1.00 0.76 1.00 0.59 
Placebo - 0.94 - 0.94 
 
The sensitivity is calculated as the probability of being classified as hyper- or hyposensitive with 
QualST when the subject was truly hyper- or hyposensitive with QST. When no subject was classified 
as hyper- or hyposensitive, no estimate (“-“) for the sensitivity was obtained. 
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Figure 1: Change in classification from quantitative sensory testing (QST) to qualitative sensory testing 
(QualST) in healthy participants.  0: normal; 1: hypersensitivity; 2: hyposensitivity.  
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Figure 2 :  Change in classification from quantitative sensory testing (QST) to qualitative sensory testing 
(QualST) in AO patients. 0: normal; 1: hypersensitivity; 2: hyposensitivity.  
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Figure 3:  Healthy participants-reported Numerical Rating Scale (NRS) pain scores ± (SEM) after the topical 
application of capsaicin and placebo on the infra-orbital region. The results represent mean values (n = 18) 
obtained during the 5 min recording period.  
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Figure 4 :  Mean (±SD) of quantitative sensory testing (QST) parameters for tested condition before and 
after application in healthy participants.  
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Figure 5:  Mean (±SD) of quantitative sensory testing (QST) parameters for tested condition before and 
after application in healthy participants.  
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Figure 6: Individual Z-score-based quantitative sensory testing (QST) profiles from the infraorbital region 
after the application of capsaicin and placebo in healthy participants and the averaged Z-scores (C) (n = 
18). The grey area (−1.96 < z < 1.96) is the normal range based on the healthy reference. CDT: cold 
detection threshold; WDT: warmth detection; TSL: thermal sensory limen; CPT: cold pain threshold; HPT: 
heat pain threshold; MDT: mechanical detection threshold; MPT: mechanical pain threshold; MPS: 
mechanical pain sensitivity; WUR: wind-up ratio; VDT: vibration detection threshold; PPT: pressure pain 
threshold.  
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